Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions
Resolvins are endogenous lipid mediators derived from omega-3 fatty acids. Resolvin E1 (RvE1), derived from eicosapentaenoic acid (EPA), modulates osteoclasts and immune cells in periodontal disease models. The direct role of RvE1 in bone remodeling is not well understood. The objective of this stud...
Main Authors: | Karim El Kholy, Marcelo Freire, Tsute Chen, Thomas E. Van Dyke |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01300/full |
Similar Items
-
Implants and inflammation - Where is the future?
by: Karim El Kholy, et al.
Published: (2015-01-01) -
Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis
by: Gabriel Mizraji, et al.
Published: (2018-04-01) -
Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation Via Shared and Distinct Molecular Counter-Regulatory Pathways
by: Bruce D Levy
Published: (2012-12-01) -
The mechanism of osteoblast response to resolvin E1
by: Yaghmoor, Wael E.
Published: (2019) -
In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis
by: Houda Abir Benabdoun, et al.
Published: (2019-03-01)